Evidence map›Paper›PMID 32457749›Full record

ArticleFrontiers in immunology2020

The Antimicrobial Peptide Human Beta-Defensin 2 Inhibits Biofilm Production of

Kevin R Parducho, Brent Beadell, Tiffany K Ybarra, Mabel Bush, Erick Escalera, Aldo T Trejos, Andy Chieng, Marlon Mendez, Chance Anderson, Hyunsook Park and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 50 citations in OpenAlex.

  1. Computer-Aided Design ofACS medicinal chemistry letters · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Establishment of Baseline Urinary Antimicrobial Peptide Levels by Age: A Prospective Observational Study.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Observational
  9. Review
  10. Article
  11. Article
  12. Article
  13. Oral streptococci: modulators of health and disease.Frontiers in cellular and infection microbiology · 2024
    Review
  14. Article
  15. Review
  16. Anti-Frontiers in microbiology · 2023
    Review
  17. Review
  18. Role of defensins in diabetic wound healing.World journal of diabetes · 2022
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Kevin R ParduchoDepartment of Biological Sciences, California State University, Los Angeles, Los Angeles, CA, United States.
Brent BeadellDepartment of Biological Sciences, California State University, Los Angeles, Los Angeles, CA, United States.
Tiffany K YbarraDepartment of Biological Sciences, California State University, Los Angeles, Los Angeles, CA, United States.
Mabel BushDepartment of Biological Sciences, California State University, Los Angeles, Los Angeles, CA, United States.
Erick EscaleraDepartment of Biological Sciences, California State University, Los Angeles, Los Angeles, CA, United States.
Aldo T TrejosDepartment of Biological Sciences, California State University, Los Angeles, Los Angeles, CA, United States.
Andy ChiengDepartment of Chemistry and Biochemistry, California State University, Los Angeles, Los Angeles, CA, United States.
Marlon MendezDepartment of Biological Sciences, California State University, Los Angeles, Los Angeles, CA, United States.
Chance AndersonDepartment of Biological Sciences, California State University, Los Angeles, Los Angeles, CA, United States.
Hyunsook ParkDepartment of Biological Sciences, California State University, Los Angeles, Los Angeles, CA, United States.
Yixian WangDepartment of Chemistry and Biochemistry, California State University, Los Angeles, Los Angeles, CA, United States.
Wuyuan LuInstitute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, United States.
Edith PorterDepartment of Biological Sciences, California State University, Los Angeles, Los Angeles, CA, United States.
California State University Los Angeles · USUniversity of Maryland, Baltimore · US

Funding

Research Initiative for Scientific Enhancement (RISE)R25GM061331 · NIGMS · CALIFORNIA STATE UNIVERSITY LOS ANGELES · PI FOSTER, KRISHNA L · 2000 to 2021
$33.1M
LOS ANGELES BASIN BRIDGES TO THE PHD PROGRAMR25GM054939 · NIGMS · CALIFORNIA STATE UNIVERSITY LOS ANGELES · PI DRAKE REITAN, MEREDITH, GUTIERREZ, CARLOS GABRIEL · 1996 to 2020
$3.4M
Lipid Effector Molecules of Innate Immunity: Antimicrobial Cholesteryl EstersSC1GM096916 · NIGMS · CALIFORNIA STATE UNIVERSITY LOS ANGELES · PI PORTER, EDITH · 2011 to 2014
$1.2M
NIGMS NIH HHS R25 GM054939NIGMS NIH HHS R25 GM061331NIGMS NIH HHS SC1 GM096916
6 · The paper itself

Abstract

Biofilm production is a key virulence factor that facilitates bacterial colonization on host surfaces and is regulated by complex pathways, including quorum sensing, that also control pigment production, among others. To limit colonization, epithelial cells, as part of the first line of defense, utilize a variety of antimicrobial peptides (AMPs) including defensins. Pore formation is the best investigated mechanism for the bactericidal activity of AMPs. Considering the induction of human beta-defensin 2 (HBD2) secretion to the epithelial surface in response to bacteria and the importance of biofilm in microbial infection, we hypothesized that HBD2 has biofilm inhibitory activity. We assessed the viability and biofilm formation of a pyorubin-producing

Indexed as

beta-DefensinsBiofilmsCells, CulturedHumansMetabolic Networks and PathwaysMicrobial ViabilityMicroscopy, Atomic ForceOrganic ChemicalsPseudomonas aeruginosaQuorum SensingSignal Transductionbeta-DefensinsDEFB4A protein, humanOrganic Chemicalspyorubinairwaysantimicrobial peptidesbiofilmcystic fibrosisepithelial cellsinnate immunitymucosaPseudomonas aeruginosa

Identifiers

PMID32457749
PMCPMC7225314
OpenAlexW3023198326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.